Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Expression and significance of IGF-1 and IGF-1R in thyroid nodules.

Liu YJ, Qiang W, Shi J, Lv SQ, Ji MJ, Shi BY.

Endocrine. 2013 Aug;44(1):158-64. doi: 10.1007/s12020-012-9864-z. Epub 2013 Jan 4.

PMID:
23288662
2.

An antibody-like peptide that recognizes malignancy among thyroid nodules.

Reis CF, Carneiro AP, Vieira CU, Fujimura PT, Morari EC, Silva SJ, Goulart LR, Ward LS.

Cancer Lett. 2013 Jul 28;335(2):306-13. doi: 10.1016/j.canlet.2013.02.039. Epub 2013 Feb 24.

3.

Muc-1 expression may help characterize thyroid nodules but does not predict patients' outcome.

Morari EC, Silva JR, Guilhen AC, Cunha LL, Marcello MA, Soares FA, Vassallo J, Ward LS.

Endocr Pathol. 2010 Dec;21(4):242-9. doi: 10.1007/s12022-010-9137-4.

PMID:
21057891
4.

[Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].

Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP.

Zhonghua Bing Li Xue Za Zhi. 2004 Jun;33(3):212-6. Chinese.

PMID:
15256110
5.

Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.

Abd-El Raouf SM, Ibrahim TR.

Pathol Res Pract. 2014 Dec;210(12):971-8. doi: 10.1016/j.prp.2014.06.010. Epub 2014 Jun 27.

PMID:
25041837
6.

In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.

Guo Z, Hardin H, Montemayor-Garcia C, Asioli S, Righi A, Maletta F, Sapino A, Lloyd RV.

Endocr Pathol. 2015 May;26(2):157-63. doi: 10.1007/s12022-015-9363-x.

PMID:
25771986
7.

[Expression of BRAF V600E mutation in different thyroid lesions].

Wang W, Li XH, Zhang YH, Li J, Chen J, Zhao P, Li QY, Xiang JJ, Li X, Xu RJ.

Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):354-7. Chinese.

PMID:
21875464
8.

[Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules].

Wang LH, Zhao YJ, Wang XY, Yuan P, Xu WQ, Xiao JC, Xu JP, Luo BR.

Zhonghua Zhong Liu Za Zhi. 2005 Sep;27(9):547-50. Chinese.

PMID:
16438854
9.

CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study.

Prasad ML, Pellegata NS, Kloos RT, Barbacioru C, Huang Y, de la Chapelle A.

Thyroid. 2004 Mar;14(3):169-75.

PMID:
15072698
10.

Diagnostic utility of IMP3 expression in thyroid neoplasms: a quantitative RT-PCR study.

Jin L, Seys AR, Zhang S, Erickson-Johnson MR, Roth CW, Evers BR, Oliveira AM, Lloyd RV.

Diagn Mol Pathol. 2010 Jun;19(2):63-9. doi: 10.1097/PDM.0b013e3181b6a528.

PMID:
20502182
11.

Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors.

Slosar M, Vohra P, Prasad M, Fischer A, Quinlan R, Khan A.

Endocr Pathol. 2009 Fall;20(3):149-57. doi: 10.1007/s12022-009-9079-x.

PMID:
19449140
12.

Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.

Brzeziańska E, Cyniak-Magierska A, Sporny S, Pastuszak-Lewandoska D, Lewiński A.

Neuro Endocrinol Lett. 2007 Aug;28(4):341-50.

PMID:
17693985
13.

Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours.

Sheu SY, Grabellus F, Schwertheim S, Worm K, Broecker-Preuss M, Schmid KW.

Br J Cancer. 2010 Jan 19;102(2):376-82. doi: 10.1038/sj.bjc.6605493. Epub 2009 Dec 22.

14.
16.

Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.

Kebebew E, Peng M, Reiff E, Duh QY, Clark OH, McMillan A.

Surgery. 2005 Dec;138(6):1102-9; discussion 1109-10.

PMID:
16360397
17.

Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours.

Fuhrer D, Eszlinger M, Karger S, Krause K, Engelhardt C, Hasenclever D, Dralle H, Paschke R.

Eur J Endocrinol. 2005 May;152(5):785-90.

18.
19.

Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules.

Mai KT, Ford JC, Yazdi HM, Perkins DG, Commons AS.

Pathol Res Pract. 2000;196(8):533-40.

PMID:
10982016
20.

HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.

Jin L, Lloyd RV, Nassar A, Lappinga PJ, Sebo TJ, Swartz K, Seys AR, Erickson-Johnson MR, Roth CW, Evers BR, Oliveira AM, Zhang J.

Diagn Mol Pathol. 2011 Jun;20(2):71-80. doi: 10.1097/PDM.0b013e3181ed784d.

PMID:
21532495
Items per page

Supplemental Content

Write to the Help Desk